XML 34 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenues:    
Product sales $ 89,978 $ 87,478
Royalties, fees and other 6,078 4,870
Total revenues 96,056 92,348
Cost of product sales 28,438 28,328
Gross profit 67,618 64,020
Operating expenses:    
Research and development 8,028 8,445
Sales and marketing 30,526 30,332
General and administrative 14,151 7,458
Amortization of intangible assets 524 423
Exit costs 0 0
Investigation and restatement related costs 5,187 3,893
Total operating expenses 58,416 50,551
Income from operations 9,202 13,469
Non-operating gains (losses) (1,127) 522
Income before income taxes 8,075 13,991
Income tax provision 1,857 2,806
Net income 6,218 11,185
Accrued dividend and accretion charges on Series A 3% Redeemable Convertible Preferred Stock (2,591) (919)
Net income available to common stockholders 3,627 10,266
Other comprehensive income (loss)    
Foreign currency translation adjustments 469 (1,099)
Total comprehensive income $ 6,687 $ 10,086
Weighted average shares outstanding:    
Basic (in shares) 31,837 28,055
Diluted (in shares) 32,654 28,785
Earnings per share applicable to common stockholders:    
Basic (in dollars per share) $ 0.11 $ 0.30
Diluted (in dollars per share) $ 0.10 $ 0.30